UL Solutions executive reports new dividend-equivalent RSU awards
UL Solutions Inc. executive reports additional stock-based awards tied to existing grants.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
UL Solutions Inc. executive reports additional stock-based awards tied to existing grants. A company officer filed a Form 4 for transactions dated 12/08/2025 showing accrual of dividend equivalent rights on restricted stock units, which are payable in Class A Common Stock. One derivative line reflects 26 restricted stock unit-related dividend equivalents at an exercise price of $0, bringing the total related derivative securities beneficially owned to 16,004. A second line shows 8 similar dividend equivalent rights at an exercise price of $0, with 5,212 such derivative securities beneficially owned after the transaction. These dividend equivalents vest proportionately with the underlying restricted stock units, which are scheduled to vest in three equal installments on the first, second and third anniversaries of March 3, 2025 and April 1, 2025, respectively.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 26 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 8 | $0.00 | $0.00 |
Footnotes (5)
- F1. Each dividend equivalent right represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2. Represents accrual of dividend equivalent rights on restricted stock units held by the Reporting Person.
- F3. The dividend equivalent rights accrued on restricted stock units held by the Reporting Person and vest proportionately with the restricted stock units to which they relate. The restricted stock units will vest in three equal installments on the first, second and third anniversaries of March 3, 2025.
- F4. Includes restricted stock units and all dividend equivalent rights that have accrued on such restricted stock units to date.
- F5. The dividend equivalent rights accrued on restricted stock units held by the Reporting Person and vest proportionately with the restricted stock units to which they relate. The restricted stock units will vest in three equal installments on the first, second and third anniversaries of April 1, 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did UL Solutions Inc. (ULS) report in this Form 4?
The filing reports that a UL Solutions Inc. officer received additional dividend equivalent rights on existing restricted stock units, which are settled in shares of Class A Common Stock.
How many dividend equivalent rights were reported by the UL Solutions (ULS) officer?
The officer reported 26 dividend equivalent rights tied to restricted stock units in one entry and 8 in a second entry, each representing a right to receive one share of Class A Common Stock.
What is the vesting schedule for the UL Solutions (ULS) restricted stock units linked to these dividend equivalents?
The dividend equivalent rights vest proportionately with the related restricted stock units, which will vest in three equal installments on the first, second and third anniversaries of March 3, 2025 and April 1, 2025.
What was the reported exercise price of the UL Solutions (ULS) dividend equivalent rights?
The derivative securities representing dividend equivalent rights were reported with an exercise price of $0.
What is the reporting person’s role at UL Solutions Inc. (ULS)?
The reporting person serves as Executive Vice President and President, Testing, Inspection and Certification at UL Solutions Inc.
How many derivative securities did the UL Solutions (ULS) officer beneficially own after these transactions?
After the reported transactions, one line shows 16,004 derivative securities beneficially owned and another shows 5,212 derivative securities beneficially owned, each tied to restricted stock units and associated dividend equivalent rights.
AI-generated analysis. How Rhea-AI works. Not financial advice.